scholarly journals Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry

Author(s):  
C. Christofer Juhlin

AbstractAbdominal paragangliomas and pheochromocytomas (PPGLs) are rare neuroendocrine tumors of the infradiaphragmatic paraganglia and adrenal medulla, respectively. Although few pathologists outside of endocrine tertiary centers will ever diagnose such a lesion, the tumors are well known through the medical community—possible due to a combination of the sheer rarity, their often-spectacular presentation due to excess catecholamine secretion as well as their unrivaled coupling to constitutional susceptibility gene mutations and hereditary syndromes. All PPGLs are thought to harbor malignant potential, and therefore pose several challenges to the practicing pathologist. Specifically, a responsible diagnostician should recognize both the capacity and limitations of histological, immunohistochemical, and molecular algorithms to pinpoint high risk for future metastatic disease. This focused review aims to provide the surgical pathologist with a condensed update regarding the current strategies available in order to deliver an accurate prognostication of these enigmatic lesions.

2016 ◽  
Vol 20 (6) ◽  
pp. 629
Author(s):  
Seung-Yeol Na ◽  
Ki-Hwan Kim ◽  
Mi-Sung Choi ◽  
Kang-Su Ha ◽  
Dong-Yoon Lim

2017 ◽  
Vol 24 (10) ◽  
pp. T195-T208 ◽  
Author(s):  
Rami Alrezk ◽  
Fady Hannah-Shmouni ◽  
Constantine A Stratakis

Multiple endocrine neoplasia (MEN) refers to a group of autosomal dominant disorders with generally high penetrance that lead to the development of a wide spectrum of endocrine and non-endocrine manifestations. The most frequent among these conditions is MEN type 1 (MEN1), which is caused by germline heterozygous loss-of-function mutations in the tumor suppressor geneMEN1. MEN1 is characterized by primary hyperparathyroidism (PHPT) and functional or nonfunctional pancreatic neuroendocrine tumors and pituitary adenomas. Approximately 10% of patients with familial or sporadic MEN1-like phenotype do not haveMEN1mutations or deletions. A novel MEN syndrome was discovered, initially in rats (MENX), and later in humans (MEN4), which is caused by germline mutations in the putative tumor suppressorCDKN1B. The most common phenotype of the 19 established cases of MEN4 that have been described to date is PHPT followed by pituitary adenomas. Recently, somatic or germline mutations inCDKN1Bwere also identified in patients with sporadic PHPT, small intestinal neuroendocrine tumors, lymphoma and breast cancer, demonstrating a novel role forCDKN1Bas a tumor susceptibility gene for other neoplasms. In this review, we report on the genetic characterization and clinical features of MEN4.


2019 ◽  
Vol 152 (1) ◽  
pp. 20-25 ◽  
Author(s):  
Beverly Long ◽  
Jenna Lilyquist ◽  
Amy Weaver ◽  
Chunling Hu ◽  
Rohan Gnanaolivu ◽  
...  

Oral Oncology ◽  
2017 ◽  
Vol 73 ◽  
pp. 77-82 ◽  
Author(s):  
Taru Ilmarinen ◽  
Pauliina Munne ◽  
Jaana Hagström ◽  
Caj Haglund ◽  
Eeva Auvinen ◽  
...  

2014 ◽  
Vol 18 (4 (72)) ◽  
Author(s):  
T. V. Kruk ◽  
O. P. Peresunko ◽  
R. A. Volkov

Based on genotyping study of two variants (GSTP1 and GSTT1) of gene mutations glutathione-Stransferase (GST) in the blood plasma of patients with breast cancer, relatives of I degree of kinship and healthy women of Chernivtsi region, we made a conclusion as to the usefulness of this study as additional molecular genetic marker, determining high-risk disease as a prognostic factor for further observation and specifying diagnostics.


1991 ◽  
Vol 444 (1) ◽  
pp. 349-362 ◽  
Author(s):  
T D Wakade ◽  
M A Blank ◽  
R K Malhotra ◽  
R Pourcho ◽  
A R Wakade

Sign in / Sign up

Export Citation Format

Share Document